Bibliografie tematiche / Vascular endothelial growth factor / Libri

Libri sul tema "Vascular endothelial growth factor"

Segui questo link per vedere altri tipi di pubblicazioni sul tema: Vascular endothelial growth factor.
Autore: Grafiati
Pubblicato: 4 giugno 2021
Ultima modifica: 20 febbraio 2023

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Vedi i top-50 libri per l'attività di ricerca sul tema "Vascular endothelial growth factor".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Vedi i libri di molte aree scientifiche e compila una bibliografia corretta.

1

Woods, Stacy Ann. Signalling pathways regulating expression of vascular endothelial growth factor in human malignant astrocytomas. Ottawa: National Library of Canada, 2001.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Perlmutter, Robin Alexandra. Differential effects of platelet-derived growth factor isoforms on large and small vessel endothelial cells and vascular smooth muscle cells. [s.l: s.n.], 1992.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Liu, Bo. A study of the biological functions of vascular endothelial growth factor in tumour development. Birmingham: University of Birmingham, 1997.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Dunk, Caroline Elizabeth. The role of the vascular endothelial growth factor family in trophoblast and endothelial cell function: Relating to placental development. Birmingham: University of Birmingham, 1999.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
5

International Workshop "Novel Angiogenic Mechanisms" (2002 Columbus, Ohio). Novel angiogenic mechanisms: Role of circulating progenitor endothelial cells. New York: Kluwer Academic/Plenum, 2003.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
6

I, Moldovan Nicanor, a cura di. Novel angiogenic mechanisms: Role of circulating progenitor endothelial cells. New York: Kluwer Academic/Plenum, 2003.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Bayko, Liisa Ann. The contribution of vascular endothelial growth factor induced angiogenesis to the progression of primary human melanoma. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1999.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
8

service), ScienceDirect (Online, a cura di. Tissue-specific vascular endothelial signals and vector targeting. Amsterdam: Elsevier, 2009.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
9

Sisi, Paraskevi. Investigation of the role of vascular endothelial growth factor in the process of cervical ripening during parturition. Birmingham: University of Birmingham, 1997.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
10

Fuchs, Johanna. Photodynamische - und anti - VEGF-Therapie als Kombinationstherapie bei der exsudativen altersabhängigen Makuladegeneration. Regensburg: Universitätsbibliothek Regensburg, 2017.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
11

Veillette, Christian J. H. Role of endothelin-1 in regulation of osteoblast differentiation and vascular endothelial growth factor-A in cell populations from fetal rat calvaria. Ottawa: National Library of Canada, 2002.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
12

Bandello, F. Anti-VEGF. Basel: Karger, 2010.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
13

Anti-VEGF. Basel: Karger, 2010.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
14

Harmey, Judith H. VEGF and cancer. Georgetown, Tex: Landes Bioscience/Eurekah.com, 2004.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
15

Modeling tumor vasculature: Molecular, cellular, and tissue level aspects and implications. New York: Springer, 2012.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
16

Kelleher, Siobhan. Signal transduction by endothelial cells: Investigation of early effects. Dublin: University College Dublin, 1998.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
17

Sutton, Andrew Bryan. The response of endothelial cells and pericytes to transforming growth factor beta. Manchester: University of Manchester, 1993.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
18

Wang, David I. Kuo. The effects of fibroblast growth factor 2 on the early stages on in vitro endothelial wound repair. Ottawa: National Library of Canada, 1998.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
19

Arciniegas, Enrique A. The phenotype of vascular cells in culture: Regulation by transforming growth factor Beta-1. Manchester: University of Manchester, 1995.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
20

Brozowski, Christine E. Effect of transforming growth factor-β1: Fibronectin and plasminogen activator inhibitor on migration of bovine aortic endothelial cells. [New Haven, Conn: s.n.], 1996.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
21

International Symposium on Biotechnology of Growth Factors: Vascular and Nervous Systems (1991 Milan, Italy). Growth factors of the vascular and nervous systems: Functional characterization and biotechnology. A cura di Albertini Alberto, Lenfant Claude e Paoletti Rodolfo. Basel: Karger, 1992.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
22

Huang, Kui. Vascular Endothelial Growth Factor Receptors in Angiogenesis. Uppsala Universitet, 2001.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
23

Parker, Marcellus L. Vascular Endothelial Growth Factor: Biology, Regulation and Clinical Significance. Nova Science Publishers, Incorporated, 2013.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
24

Claesson-Welsh, Lena. Vascular Growth Factors and Angiogenesis (Current Topics in Microbiology and Immunology). Springer-Verlag Telos, 1998.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
25

Ruhrberg, Christiana. VEGF in Development. Springer, 2009.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
26

Ruhrberg, Christiana. VEGF in Development. Springer London, Limited, 2008.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
27

Christiana, Ruhrberg, a cura di. VEGF in development. Austin, Tex: Landes Bioscience/Eurekah.com, 2008.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
28

Rubanyi, Gabor M., e Werner Risau. Morphogenesis of Endothelium (Endothelial Cell Research Series). CRC, 2000.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
29

Michael, Simons, e Rubanyi Gabor M. 1947-, a cura di. Modern concepts in angiogenesis. London: Imperial College Press, 2007.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
30

Rubanyi, Gabor M., e Michael Simons. Modern Concepts in Angiogenesis. Imperial College Press, 2007.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
31

(Editor), Michael Simons, e Gabor M. Rubanyi (Editor), a cura di. Modern Concepts in Angiogenesis. Imperial College Press, 2007.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
32

C, Weber Peter, e Leaf Alexander 1920-, a cura di. Atherosclerosis: Cellular interactions, growth factors, and lipids. New York: Raven Press, 1993.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
33

Weber, Peter C. Atherosclerosis: Cellular Interactions, Growth Factors, and Lipids (Atherosclerosis Reviews). Raven Pr, 1993.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
34

Remesal, Ana. Effects of Oxidative Stress and Antenatal Corticosteroids on the Pulmonary Expression of Vascular Endothelial Growth Factor (VEGF) and Alveolarization. INTECH Open Access Publisher, 2012.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
35

Maes, Christa. Angiogenesis & Bone: The Role Of The Vascular Endothelial Growth Factor Family In Bone Development And Repair (Acta Biomedica Lovaniensia). Leuven Univ Pr, 2004.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
36

Beverungen, Mirjam. Überprüfung der Wirkung von gefäßinduzierenden Wachstumsfaktoren (VEGF=Vascular Endothelial Growth Factor) auf die Vaskularisierung und Osteogenese in festen Knochenersatzstoffen. 2010.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
37

Weber, Peter C. Atherosclerosis: Its Pathogenesis and the Role of Cholesterol (Atherosclerosis Reviews). Raven Pr, 1991.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
38

Processing Of Vegfc And Vegfd By The Pcs And Tumorigenesis. Biota Publishing, 2013.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
39

H, Harmey Judith, a cura di. VEGF and cancer. Georgetown, Tex: Landes Bioscience/Eurekah.com ; New York, N.Y. : Kluwer Academic/Plenum Publishers, 2004.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
40

Harmey, Judith H. VEGF and Cancer. Springer, 2012.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
41

Harmey, Judith H. VEGF and Cancer. Springer, 2004.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
42

Cimpean, Anca Maria, Andreea Adriana Jitariu e Marius Raica. Growth Factors and Their Corresponding Receptors as Targets for Ovarian Cancer Therapy. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0011.

Testo completo
Abstract (sommario):
Ovarian cancer remains one of the most aggressive and difficult to manage malignancies regarding evaluation and therapeutic options. The high mortality persists despite extensive research in the field. Current conventional chemotherapy does not improve disease-free survival and does not decrease recurrences amongst patients. This calls for a stringent reconsideration of the drugs selection, focused on the most targeted strategies and personalization of the therapy. Targeted agents against growth factors and their corresponding receptors are already approved as first- or second-line neoadjuvant therapy with controversial results. This chapter critically discusses the role of growth factors as vascular endothelial growth factor, fibroblast growth factors, or platelet-derived growth factors and their corresponding receptors in the pathogenesis, progression, and selection of therapeutic strategies. Other growth factors, such as nerve growth factor or endocrine gland derived growth factor, seem to have a strong involvement in ovarian carcinogenesis but their actual impact is not fully understood.
Gli stili APA, Harvard, Vancouver, ISO e altri
43

The Textbook Of Angiogenesis And Lymphangiogenesis Methods And Applications. Springer, 2012.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
44

Levi, Marcel, e Tom van der Poll. Coagulation and the endothelium in acute injury in the critically ill. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0307.

Testo completo
Abstract (sommario):
Vascular endothelial cells play a pivotal mediatory role in many responses to systemic inflammation, including the cross-talk between coagulation and inflammation in sepsis. Endothelial cells respond to the cytokines expressed and released by activated leukocytes, but can also release cytokines themselves. Furthermore, endothelial cells are able to express adhesion molecules and growth factors that may not only promote the inflammatory response further, but also affect a myriad of downstream responses. It has recently become clear that, in addition to these mostly indirect effects of the endothelium, injured endothelial cells directly interfere with platelet-vessel wall interactions, neutrophil entrapment through formation of extracellular nets, and activation of inflammation and coagulation mediated by microparticles. The role of the glycocalyx as an important interface between the endothelium and regulation of coagulation in inflammatory states has also gained a lot of recent attention.
Gli stili APA, Harvard, Vancouver, ISO e altri
45

G, Mikos Antonios, e Johnson Peter C, a cura di. Angiogenesis. New Rochelle, NY: Mary Ann Liebert, 2010.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
46

Angiogenesis. New Rochelle, NY: Mary Ann Liebert, 2010.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
47

G, Mikos Antonios, e Johnson Peter C, a cura di. Advances in tissue engineering angiogenesis. New Rochelle, NY: Mary Ann Liebert, Inc., 2010.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
48

Eremina, Vera. Role of vascular endothelial growth factor A in the glomerulus: Analysis of phenotypes with glomerular-specific alterations of VEGF-A expression in murine transgenic lines. 2006.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
49

Woywodt, Alexander, e Diana Chiu. Drug-induced and toxic glomerulopathies. A cura di Neil Turner. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0082.

Testo completo
Abstract (sommario):
Glomerulopathies induced by particular exogenous compounds or molecules include those attributable to toxicity, and those caused by inducing an immune or autoimmune response. Tubules are more commonly the target of toxicity as they absorb and concentrate components of filtrate. Damage to endothelial cells may account for thrombotic microangiopathy in response to calcineurin inhibitors. Endothelial cells are also likely to be the target in drug-induced small vessel vasculitis. Toxicity to podocytes accounts for focal segmental glomerulosclerosis caused by pamidronate and other agents. Chloroquine can cause a remarkable pseudo-storage disorder with inclusions in podocytes that resemble those seen in Fabry disease. The mechanism by which drugs cause minimal change disease, another podocyte disorder, is not known. Membranous nephropathy may be caused by exposure to gold, mercury, and some other drugs; this is antibody mediated and presumably the targets are altered podocyte surface molecules. Inhibitors of the mammalian target of rapamycin (mTOR) cause proteinuria, possibly through effects on vascular endothelial growth factor, inhibitors of which are associated with not only proteinuria (an expected podocyte effect) but also thrombotic microangiopathy (endothelial cell effect). This latter may be through disturbing podocyte-endothelium cross-signaling.
Gli stili APA, Harvard, Vancouver, ISO e altri
50

Maragoudakis, Michael E. Angiogenesis: Models, Modulators, and Clinical Applications. Springer, 2014.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
Ti possono interessare anche gli elenchi di altri tipi di fonti sul tema "Vascular endothelial growth factor":
Articoli di riviste Tesi
Offriamo sconti su tutti i piani premium per gli autori le cui opere sono incluse in raccolte letterarie tematiche. Contattaci per ottenere un codice promozionale unico!

Vai alla bibliografia